Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

213.56 +2.73 (+1.29%)
Official Closing Price Updated: 4:15 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
28 29 Next >
News headline image
A Moment Of Truth - Ways To Help You Deal With A New Reality ↗
The truth can be difficult to hear. This week, investors had to deal with a heavy dose of truth about the state of the economy. Based on the markets’ response, it was painfully unexpected and... 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Can the Fed Control Inflation with Higher Rates? ↗
Today’s rally in equities might be met with further selling very soon once the market realizes that the Fed cannot go far enough. 
Via Talk Markets
News headline image
What’s Next For Biotech And Healthcare ↗
Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
For Signs of a Relief Rally, Watch the S&P 500 v. Retail ↗
With inflation on everyone’s lips and the price of gas and food showing no signs of abating, the retail sector is the key to assessing where the equity market goes from here. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Why This Biotech ETF May Be About to Break Out ↗
There’s a chance shares of the iShares Biotechnology ETF (NASDAQ: IBB) may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form. 
Via Benzinga
News headline image
Watch For The Nasdaq 100 and S&P 500 to Clear Their Mini Ranges ↗
As the current leader of the major indices, IWM has been playing a very important role in the overall market direction. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Are Gold And Silver Ready for A Momentum Breakout? ↗
Currently, SLV is looking to break over its 200-DMA. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
3 Things Need to Align for The Next Big Market Move ↗
Currently, the small-cap index Russell 2000 is leading in momentum compared to the S&P 500 and the Nasdaq 100. Last Thursday is an important day for each of the indices as it represents the high of the... 
Via Talk Markets
News headline image
Musk Stirs Up A Hornet's Nest In Epstein Case, Apple WWDC Expectations, Kim Jong-Un Goes Ballistic And More: 5 Key Stories You May Have Missed From This Weekend ↗
Just as investors were hoping for an inflection higher, a strong non-farm payroll report proved to be the undoing of markets in the week ending June 3. Investors are still left to grapple with a fluid... 
Via Benzinga
News headline image
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
News headline image
Is the Stock Market Looking for Temporary Relief? ↗
There is no doubt that the stock market is in a tough spot fundamentally with increasing interest rates, inflation, and a downward trend from the technical side. 
Via Talk Markets
News headline image
What Does a Trading Range Look Like? ↗
Buying ahead of taking out last week's high was premature. Getting overly negative unless we fail last week’s low is equally premature. 
Via Talk Markets
News headline image
3 Biotech Stocks to Buy Before They Boom ↗
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. 
Via InvestorPlace
News headline image
Can Big Tech Save the Day Again? ↗
Nasdaq spent most of the day green, only to close down .18% in the last few minutes of the session. 
Via Talk Markets
News headline image
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
Via Benzinga
News headline image
Bill Gates' Tesla Short Bet Balloons, Astute Investors Reap Luna Windfall, Giga Shanghai Update And More: 5 Key Stories You May Have Missed Memorial Day Weekend ↗
The market is set to open following the long weekend in observance of the Memorial Day holiday. As investors look ahead to a fresh trading week, hoping for an extension of the... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
News headline image
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats ↗
The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support. 
Via Benzinga
News headline image
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.